INTEG-B Integrum AB (publ)

STO · SE · Healthcare · Medical Devices · integrum.se

9.070SEK+1.23%Mkt Cap: 22.86M $P/E: —Today

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses syste…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap22.86M USD

Enterprise Value21.68M USD

Revenue (TTM)9.36M USD

Gross Profit6.05M USD

Net Income (TTM)-4.43M USD

Revenue/Share3.95 SEK

Last Price9.070 SEK

Fiscal Year EndApr 2026

MR QuarterJul 2026

Employees33

CountrySE

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-8.69

EV/Revenue2.32

P/S2.44

P/B1.37

EPS (TTM)-1.45

EPS (Forward)—

52W Range

6.40029% of range15.46

52W High15.46 SEK

52W Low6.400 SEK

Profitability

Gross Margin69.19%

Oper. Margin7.43%

EBITDA Margin-26.64%

Profit Margin-50.71%

ROE-26.94%

ROA-22.76%

Growth

Revenue Growth27.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-3.92M USD

CapEx (TTM)1.62M USD

FCF Margin-30.80%

FCF Yield-12.62%

Net Debt-1.17M USD

Net Debt/EBITDA0.47

Balance Sheet

Debt/Equity0.02

Current Ratio3.33

Quick Ratio1.96

Book Value/Sh6.53 SEK

Cash/Share0.56 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.26.03M

Float16.15M

Insiders25.98%

Institutions18.59%

Technical

SMA 508.832 (+2.7%)

SMA 2008.510 (+6.6%)

Beta0.39

S&P 52W Chg14.58%

Avg Vol (30d)71.48K

Avg Vol (10d)54.75K

Technical Indicators

RSI (14)46.5

MACD0.1315

MACD Signal0.2050

MACD Hist.-0.0735

BB Upper9.958 SEK

BB Middle9.237 SEK

BB Lower8.516 SEK

BB Width15.62%

ATR (14)0.4719 SEK

Vol Ratio (20d)0.51x